NDC codes

379838 NDC codes with hospital pricing data in the network.

• NDC 00409-7332-01 — CEFTRIAXONE 1 G INJ SOLR (149 hospitals, 5,027–6,422 samples)
• NDC 00781-3156-06 — ACETAMINOPHEN 10 MG/ML IV SOLN FOR PDA CLOSURE (56 hospitals, 6,412–6,421 samples)
• NDC 00264-5535-32 — METRONIDAZOLE (FLAGYL) IVPB (71 hospitals, 6,402–6,420 samples)
• NDC 00068-0597-01 — RIFAMPIN 600 MG/10ML IV (WET SOLR VIAL) (168 hospitals, 6,200–6,416 samples)
• NDC 00904-6667-61 — GABAPENTIN 400 MG PO CAPS (105 hospitals, 6,200–6,416 samples)
• NDC 63739-0570-10 — SIMVASTATIN 5 MG TABLET (25 hospitals, 6,200–6,416 samples)
• NDC 25021031905 — DILTIAZEM HCL 25 MG/5ML IV SOLN (155 hospitals, 5,028–6,414 samples)
• NDC 63323-0165-01 — DEXAMETHASONE SODIUM PHOSPHATE (177 hospitals, 5,458–6,412 samples)
• NDC 83090000701 — LIDOCAINE (PF) 40 MG/ML (4 %) INJECTION SOLUTION (39 hospitals, 5,053–6,394 samples)
• NDC 83090000710 — lidocaine 4% *PF* inj 5 mL (62 hospitals, 5,053–6,394 samples)
• NDC 63323049216 — Lidocaine HCl Local Preservative Free (PF) Inj 1% (82 hospitals, 5,029–6,361 samples)
• NDC 65219-0383-04 — LOW OSMOLAR CONTRAST MATERIAL, 300-399 MG/ML IODINE CONCENTRATION, PER ML (19 hospitals, 6,128–6,353 samples)
• NDC 71351002105 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (52 hospitals, 4,985–6,353 samples)
• NDC 409471302 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (101 hospitals, 6,129–6,345 samples)
• NDC 00409428212 — Lidocaine Hcl Local Preservative Free (Pf) Inj 2% (97 hospitals, 5,006–6,338 samples)
• NDC 00409733701 — Ceftriaxone Sodium: 10 Vial, Single-Use In 1 Carton (0409-7337-01) / 1 Injection, Powder, For Solution In 1 Vial, Single-Use (0409-7337-11) (175 hospitals, 4,168–6,337 samples)
• NDC 00904-6666-61 — GABAPENTIN 300 MG CAP (127 hospitals, 6,074–6,335 samples)
• NDC 00378-0144-91 — TAMOXIFEN 10 MG ORAL TAB (62 hospitals, 6,074–6,335 samples)
• NDC 00270131430 — iopamidol 41 % Soln 50 mL Vial (37 hospitals, 4,607–6,335 samples)
• NDC 00409318301 — Lidocaine 2%-Epi 1:200,000 (206 hospitals, 2,725–6,334 samples)
• NDC 70756064625 — lidocaine 10 mg/mL (1 %) solution 20 mL Vial (73 hospitals, 4,993–6,334 samples)
• NDC 00409471332 — Lidocaine Hydrochloride: 5 Carton In 1 Package (0409-4713-32) / 10 Ampule In 1 Carton (0409-4713-25) / 2 Ml In 1 Ampule (0409-4713-42) (157 hospitals, 4,983–6,333 samples)
• NDC 63323080601 — FENTANYL 0.05 MG/ML SOLUTION (207 hospitals, 2,831–6,332 samples)
• NDC 00009003906 — METHYLPREDNISOLONE SOD SUCC (ALL) 40 MG/ML SOLUTION (84 hospitals, 3,810–6,330 samples)
• NDC 00409427816 — LIDOCAINE (PF) 5 MG/ML (0.5 %) INJECTION SOLUTION (93 hospitals, 4,995–6,327 samples)
• NDC 00009004704 — METHYLPREDNISOLONE SODIUM SUCC 125 MG IJ SOLR (WRAPPED) (52 hospitals, 3,715–6,325 samples)
• NDC 47335-0485-83 — BICALUTAMIDE 50 MG TABLET (72 hospitals, 6,134–6,323 samples)
• NDC 00409471342 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (88 hospitals, 5,004–6,318 samples)
• NDC 00487590199 — RACEPINEPHRINE 2.25 % SOLUTION FOR NEBULIZATION (249 hospitals, 4,688–6,317 samples)
• NDC 72572-0750-10 — SUCCINYLCHOLINE CHLORIDE 20 MG/ML INJECTION SOLUTION (WRAPPER) (11 hospitals, 6,129–6,309 samples)
• NDC 68516521608 — Albumin, Human Inj 25% (120 hospitals, 1,629–6,309 samples)
• NDC 00409132315 — LIDOCAINE (PF) 100 MG/5 ML (2 %) INTRAVENOUS SYRINGE (121 hospitals, 4,980–6,303 samples)
• NDC 51672409103 — ondansetron 0.8 mg/mL *PEDS* oral liq 1 mL (98 hospitals, 3,971–6,302 samples)
• NDC 76154081215 — EPINEPHRINE HCL 4 MG/250 ML (16 MCG/ML) IN 0.9 % SODIUM CHLOR IV SOLN (28 hospitals, 5,434–6,298 samples)
• NDC 00338979140 — SODIUM CHLORIDE IV SOLN 0.9% (14 hospitals, 6,154–6,298 samples)
• NDC 63323049397 — Lidocaine HCl Local Preservative Free (PF) Inj 1.5 (60 hospitals, 4,979–6,293 samples)
• NDC 63323049391 — LIDOCAINE HCL LOCAL PRESERVATIVE FREE (PF) INJ 1.5% (104 hospitals, 4,979–6,293 samples)
• NDC 00409427516 — LIDOCAINE HCL 5 MG/ML (0.5 %) INJECTION SOLUTION (37 hospitals, 4,979–6,293 samples)
• NDC 00409427617 — lidocaine 10 mg/mL (1 %) solution 50 mL Vial (80 hospitals, 4,979–6,293 samples)
• NDC 00143957501 — NDC Description Not Available (76 hospitals, 4,979–6,293 samples)
• NDC 00143957701 — LIDOCAINE 1% INJ 50 ML MDV (75 hospitals, 4,979–6,293 samples)
• NDC 00143957710 — LIDOCAINE HCL 10 MG/ML (1 %) INJECTION SOLUTION (112 hospitals, 4,979–6,293 samples)
• NDC 00409471312 — LIDOCAINE HCL LOCAL PRESERVATIVE FREE (PF) INJ 1% (64 hospitals, 4,979–6,293 samples)
• NDC 00409471325 — LIDOCAINE HCL (PF) 1 % IJ SOLN (27 hospitals, 4,979–6,293 samples)
• NDC 63739017027 — LIDOCAINE HCL 1 % IJ SOLN (54 hospitals, 4,979–6,293 samples)
• NDC 00409427717 — LIDOCAINE HCL 20 MG/ML (2 %) INJECTION SOLUTION (68 hospitals, 4,979–6,293 samples)
• NDC 69374052005 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (73 hospitals, 4,979–6,293 samples)
• NDC 83090000310 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (44 hospitals, 4,979–6,293 samples)
• NDC 63323048641 — Lidocaine HCl Local Inj 2% (24 hospitals, 4,979–6,293 samples)
• NDC 83090000301 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (29 hospitals, 4,979–6,293 samples)